Mehdi Nosrati Selected Research

Mehdi Nosrati Research Topics

Disease

29	Neoplasms (Cancer) 04/2024 - 03/2002
24	Melanoma (Melanoma, Malignant) 04/2024 - 03/2002
12	Neoplasm Metastasis (Metastasis) 04/2024 - 03/2002
3	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2016
3	Cholangiocarcinoma 08/2021 - 10/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2020
1	Genomic Instability 08/2021
1	Carcinogenesis 01/2021
1	Cutaneous Malignant Melanoma 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Triple Negative Breast Neoplasms 04/2016
1	Neuroblastoma 05/2012
1	Cachexia 10/2010
1	Lymphatic Metastasis 01/2008
1	Disease Progression 01/2008

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2008
6	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 04/2024 - 05/2012
5	Catalytic RNA (Ribozymes)IBA 03/2009 - 03/2002
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2004
4	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2012
4	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2007 - 08/2004
3	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 08/2004
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2018
3	telomerase RNA (bTR)IBA 01/2007 - 08/2004
2	Circulating Tumor DNAIBA 05/2023 - 11/2022
2	Mitogen-Activated Protein KinasesIBA 01/2023 - 01/2022
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2020
2	LigandsIBA 01/2023 - 03/2002
2	bromosporineIBA 01/2022 - 01/2022
2	Complementary DNA (cDNA)IBA 01/2022 - 01/2020
2	fetal Alzheimer antigenIBA 01/2022 - 02/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2021 - 01/2021
2	Gemcitabine FDA Link 08/2021 - 10/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2014
2	IntegrinsIBA 01/2020 - 03/2002
2	MicroRNAs (MicroRNA)IBA 08/2019 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 05/2016 - 03/2002
2	Platelet Endothelial Cell Adhesion Molecule-1IBA 10/2010 - 03/2002
2	NF-kappa B (NF-kB)IBA 02/2004 - 03/2002
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023
1	ChemokinesIBA 01/2023
1	sapanisertibIBA 01/2023
1	TOR Serine-Threonine KinasesIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	PeriostinIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2023
1	Cell-Free Nucleic AcidsIBA 11/2022
1	gedatolisibIBA 01/2022
1	cobimetinibIBA 01/2022
1	niraparibIBA 08/2021
1	AcidsIBA 08/2021
1	DeoxyribonucleotidesIBA 08/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2021
1	Histones (Histone)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	dinaciclibIBA 10/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2020
1	TalinIBA 01/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020
1	PaxillinIBA 01/2020
1	VinculinIBA 01/2020
1	Drug CombinationsIBA 01/2020
1	Cyclin D1IBA 01/2018
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 04/2016
1	alpha Subunit Hypoxia-Inducible Factor 1IBA 03/2014
1	Lactate Dehydrogenase 5IBA 03/2014
1	TensinsIBA 05/2012
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2012
1	Decitabine FDA Link 08/2010
1	Messenger RNA (mRNA)IBA 08/2010
1	hammerhead ribozymeIBA 03/2009
1	OsteopontinIBA 01/2008
1	Nuclear Receptor Coactivator 3IBA 10/2006
1	Monophenol Monooxygenase (Tyrosinase)IBA 07/2006
1	Melanins (Melanin)IBA 07/2006
1	Liposomes (Liposome)IBA 08/2004
1	NucleotidesIBA 08/2004

Therapy/Procedure

11	Therapeutics 04/2024 - 08/2004
2	Precision Medicine 01/2023 - 11/2022
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 10/2020
1	Radiotherapy 01/2018
1	Craniotomy 01/2018
1	Lasers (Laser) 04/2005